Beyond Conventional Glycemic Markers: One-Hour Plasma Glucose in Children and Adolescents

The increasing prevalence of obesity and dysglycemia in children and adolescents has highlighted the limitations of conventional approaches to identifying early disturbances in glucose metabolism. Fasting glucose levels, 2 h plasma glucose (2 h PG) measured during the oral glucose tolerance test (OGTT), and glycated hemoglobin (HbA1c) reflect different aspects of glucose homeostasis and show limited concordance, particularly in the pediatric population. Consequently, a proportion of young individuals at increased metabolic risk may remain classified as having normal glucose tolerance. One-hour plasma glucose (1 h PG), measured as part of the OGTT, has gained attention as a potential indicator of early metabolic deterioration. Evidence from pediatric studies indicates that elevated 1 h PG is associated with lower insulin sensitivity, compromised β-cell function, a reduced disposition index, and an unfavorable cardiometabolic profile, even in children and adolescents exhibiting normal glucose tolerance. Longitudinal data further suggest an association with subsequent progression to prediabetes. However, the optimal pediatric threshold remains uncertain. Although 155 mg/dL (8.6 mmol/L) is the most widely investigated cut-off, with considerable evidence supporting its clinical relevance, lower thresholds around 132.5–133 mg/dL have also been associated with early metabolic abnormalities in youth. Elevated 1 h PG has additionally been linked to vascular alterations, adverse cardiometabolic features, and metabolic dysfunction-associated liver disease, suggesting that its clinical relevance may extend beyond glycemic classification alone. Overall, 1 h PG represents a promising complementary marker for identifying metabolic risk before abnormalities become apparent using conventional criteria. Nevertheless, long-term pediatric data remain limited, and prospective studies across different ages, pubertal stages, and ethnic populations are needed to establish the optimal threshold and clarify its role in routine clinical practice.

Authors

Institutions

Publication Details

Journal
Children
Published
2026-10-29
DOI
https://doi.org/10.3390/children13111497
Primary Topic
Diabetes, Cardiovascular Risks, and Lipoproteins
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Beyond Conventional Glycemic Markers: One-Hour Plasma Glucose in Children and Adolescents

Eda Mengen
1 links
Children
Diabetes, Cardiovascular Risks, and Lipoproteins
article

Beyond Conventional Glycemic Markers: One-Hour Plasma Glucose in Children and Adolescents

Eda Mengen
article en

Abstract

The increasing prevalence of obesity and dysglycemia in children and adolescents has highlighted the limitations of conventional approaches to identifying early disturbances in glucose metabolism. Fasting glucose levels, 2 h plasma glucose (2 h PG) measured during the oral glucose tolerance test (OGTT), and glycated hemoglobin (HbA1c) reflect different aspects of glucose homeostasis and show limited concordance, particularly in the pediatric population. Consequently, a proportion of young individuals at increased metabolic risk may remain classified as having normal glucose tolerance. One-hour plasma glucose (1 h PG), measured as part of the OGTT, has gained attention as a potential indicator of early metabolic deterioration. Evidence from pediatric studies indicates that elevated 1 h PG is associated with lower insulin sensitivity, compromised β-cell function, a reduced disposition index, and an unfavorable cardiometabolic profile, even in children and adolescents exhibiting normal glucose tolerance. Longitudinal data further suggest an association with subsequent progression to prediabetes. However, the optimal pediatric threshold remains uncertain. Although 155 mg/dL (8.6 mmol/L) is the most widely investigated cut-off, with considerable evidence supporting its clinical relevance, lower thresholds around 132.5–133 mg/dL have also been associated with early metabolic abnormalities in youth. Elevated 1 h PG has additionally been linked to vascular alterations, adverse cardiometabolic features, and metabolic dysfunction-associated liver disease, suggesting that its clinical relevance may extend beyond glycemic classification alone. Overall, 1 h PG represents a promising complementary marker for identifying metabolic risk before abnormalities become apparent using conventional criteria. Nevertheless, long-term pediatric data remain limited, and prospective studies across different ages, pubertal stages, and ethnic populations are needed to establish the optimal threshold and clarify its role in routine clinical practice.

ChildrenVol. 13(11)
Cukurova University (TR)
Good health and well-being
Openalex Percentile: Top 11%
Diabetes, Cardiovascular Risks, and Lipoproteins
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Beyond Conventional Glycemic Markers: One-Hour Plasma Glucose in Children and Adolescents — Eda Mengen · Children (2026) | TGRS Research Map | TGRS